News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
332,923 Results
Type
Article (19982)
Company Profile (128)
Press Release (312813)
Section
Business (105380)
Career Advice (879)
Deals (18534)
Drug Delivery (97)
Drug Development (50777)
Employer Resources (79)
FDA (7685)
Job Trends (7743)
News (185872)
Policy (17330)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (733)
Accelerated approval (1)
Adcomms (17)
Allergies (40)
Alliances (27829)
ALS (53)
Alzheimer's disease (625)
Antibody-drug conjugate (ADC) (87)
Approvals (7700)
Artificial intelligence (132)
Autoimmune disease (11)
Automation (4)
Bankruptcy (177)
Best Places to Work (5553)
BIOSECURE Act (13)
Biosimilars (94)
Biotechnology (57)
Bladder cancer (30)
Brain cancer (18)
Breast cancer (104)
Cancer (1004)
Cardiovascular disease (107)
Career advice (711)
Career pathing (20)
CAR-T (53)
Cell therapy (147)
Cervical cancer (5)
Clinical research (42605)
Collaboration (442)
Compensation (147)
Complete response letters (23)
COVID-19 (1097)
CRISPR (21)
C-suite (141)
Cystic fibrosis (56)
Data (1058)
Decentralized trials (2)
Denatured (18)
Depression (24)
Diabetes (137)
Diagnostics (1807)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (21)
Drug discovery (74)
Drug pricing (108)
Drug shortages (30)
Duchenne muscular dystrophy (57)
Earnings (38978)
Editorial (29)
Employer branding (10)
Employer resources (73)
Events (48476)
Executive appointments (416)
FDA (8236)
Featured Employer (23)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (299)
Gene editing (45)
Generative AI (17)
Gene therapy (141)
GLP-1 (577)
Government (1831)
Grass and pollen (2)
Guidances (18)
Healthcare (5904)
Huntington's disease (13)
IgA nephropathy (19)
Immunology and inflammation (78)
Indications (17)
Infectious disease (1174)
Inflammatory bowel disease (82)
Inflation Reduction Act (8)
Influenza (22)
Intellectual property (52)
Interviews (116)
IPO (7366)
IRA (45)
Job creations (2432)
Job search strategy (648)
Kidney cancer (7)
Labor market (21)
Layoffs (273)
Leadership (13)
Legal (4113)
Liver cancer (31)
Lung cancer (152)
Lymphoma (82)
Machine learning (2)
Management (30)
Manufacturing (189)
MASH (46)
Medical device (1962)
Medtech (1965)
Mergers & acquisitions (11402)
Metabolic disorders (472)
Multiple sclerosis (46)
NASH (20)
Neurodegenerative disease (43)
Neuropsychiatric disorders (20)
Neuroscience (916)
NextGen: Class of 2025 (2358)
Non-profit (906)
Northern California (1026)
Now hiring (20)
Obesity (295)
Opinion (189)
Ovarian cancer (33)
Pain (65)
Pancreatic cancer (35)
Parkinson's disease (78)
Partnered (11)
Patents (130)
Patient recruitment (45)
Peanut (16)
People (33390)
Pharmaceutical (74)
Pharmacy benefit managers (21)
Phase I (13338)
Phase II (18024)
Phase III (14483)
Pipeline (660)
Podcasts (68)
Policy (101)
Postmarket research (1618)
Preclinical (4647)
Press Release (29)
Prostate cancer (58)
Psychedelics (16)
Radiopharmaceuticals (161)
Rare diseases (230)
Real estate (3170)
Recruiting (29)
Regulatory (12492)
Reports (22)
Research institute (818)
Resumes & cover letters (138)
Rett syndrome (1)
RNA editing (2)
RSV (24)
Schizophrenia (58)
Series A (55)
Series B (31)
Service/supplier (6)
Sickle cell disease (35)
Southern California (989)
Special edition (15)
Spinal muscular atrophy (111)
Sponsored (12)
Startups (2008)
State (2)
Stomach cancer (9)
Supply chain (49)
The Weekly (47)
United States (9669)
Vaccines (264)
Venture capitalists (27)
Webinars (11)
Weight loss (233)
Women's health (14)
Worklife (7)
Date
Today (124)
Last 7 days (386)
Last 30 days (1432)
Last 365 days (17097)
2025 (4180)
2024 (17669)
2023 (19638)
2022 (25865)
2021 (26639)
2020 (24870)
2019 (20057)
2018 (15587)
2017 (17253)
2016 (16202)
2015 (18801)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
Location
Africa (408)
Alabama (22)
Alaska (1)
Arizona (64)
Arkansas (8)
Asia (24852)
Australia (3209)
California (2407)
Canada (1067)
China (311)
Colorado (94)
Connecticut (96)
Delaware (68)
Europe (51283)
Florida (415)
Georgia (52)
Idaho (16)
Illinois (235)
India (18)
Indiana (168)
Iowa (3)
Japan (111)
Kansas (60)
Kentucky (17)
Louisiana (1)
Maine (4)
Maryland (353)
Massachusetts (2028)
Michigan (46)
Minnesota (132)
Mississippi (1)
Missouri (26)
Montana (10)
Nebraska (11)
Nevada (15)
New Hampshire (8)
New Jersey (979)
New Mexico (21)
New York (702)
North Carolina (484)
North Dakota (2)
Northern California (1026)
Ohio (80)
Oklahoma (5)
Oregon (21)
Pennsylvania (567)
Puerto Rico (10)
Rhode Island (13)
South America (606)
South Carolina (3)
Southern California (989)
Tennessee (38)
Texas (322)
Utah (53)
Virginia (78)
Washington D.C. (41)
Washington State (207)
Wisconsin (19)
332,923 Results for "cinrx pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
CinRx Pharma Announces Additional $73 Million Financing
CinRx Pharma today announced the closing of a $73 million financing, bringing the total funds raised to $176 million.
May 30, 2024
·
4 min read
BioMidwest
CinFina Pharma, a CinRx Portfolio Company, Introduces Scientific Advisory Board with Deep Metabolic Expertise
CinFina Pharma, CinRx Pharma’s portfolio company dedicated to expanding treatment options for obesity and metabolic diseases, announced the scientific advisory board members for the company’s multi-asset pipeline.
December 14, 2023
·
5 min read
Drug Development
CinPhloro Pharma, a CinRx Portfolio Company, Dosed First Participant in Phase 2 enviva Study of CIN-103 for Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D)
CinPhloro Pharma, a CinRx Portfolio Company, Dosed First Participant in Phase 2 enviva Study of CIN-103 for Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).
February 22, 2024
·
3 min read
BioMidwest
CinRx’s CinDome Pharma to Present a Poster on Deudomperidone (CIN-102) at 2023 Digestive Disease Week® Conference
CinRx’s CinDome Pharma to Present a Poster on Deudomperidone (CIN-102) at 2023 Digestive Disease Week ® Conference.
May 2, 2023
·
3 min read
BioMidwest
CinDome Pharma Announces $40 Million Series B Extension
CinDome Pharma, a CinRx portfolio company dedicated to advancing a safe, chronic therapy for gastroparesis, today announced a $40 million Series B financing extension.
May 16, 2024
·
3 min read
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Drug Development
CinRx Pharma Announces First Participant Dosed in CinDome’s Phase 2 Study of Deudomperidone (CIN-102) for the Treatment of Diabetic Gastroparesis
CinRx Pharma today announced that the first study participant has been dosed in CinDome Pharma’s Phase 2 envision3D study of deudomperidone (CIN-102) in patients with diabetic gastroparesis.
April 27, 2023
·
4 min read
BioMidwest
CinRx Portfolio Company CinDome Pharma Presents Encouraging Data on Deudomperidone (CIN-102) at 2023 Digestive Disease Week® Conference
CinDome Pharma, a CinRx portfolio company, presented a poster at the 2023 Digestive Disease Week Conference titled “Effect of Therapeutic and Supratherapeutic Doses of Deudomperidone on Cardiac Repolarization in a Thorough QT Study in Healthy Subjects.”
May 8, 2023
·
4 min read
Government
Trump Threatens Big Pharma With Tariffs—Unless They Reshore Manufacturing: Bloomberg
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
February 24, 2025
·
2 min read
·
Tristan Manalac
C-suite
GSK CEO Emma Walmsley Gets Pay Bump To Align With Pharma Peers
One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 million in 2025.
February 27, 2025
·
2 min read
·
Annalee Armstrong
1 of 33,293
Next
